U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07792317) titled 'Hypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation' on Aug. 24.

Brief Summary: Insufficient availability of organs from brain dead (DBD) and living donors has necessitated increased use of less than optimal organs from donation after cardiac death (DCD) or from extended criteria donors. Preservation of DCD organs using the current clinically applied preservation solutions is associated with up to 73% incidence of delayed graft function, highlighting the need for new preservation solutions designed to improve early graft function.

Omnisol is expected to result in equivalent or improved kidn...